Advent Venture Partners is a venture capital and private equity firm specializing in startups, seed, early, mid-stage, late venture, emerging growth investments, later stage, buyout, and growth capital investments.
Advent Venture Partners is a privately held venture capital & private equity company. It operates in the following areas: venture capital, growth capital, technology, digital media, e-commerce, internet, mobile, software, cleantech, consumer, life sciences, biotech, biopharma, medical devices, platform technologies, and financing.
The firm prefers to invest in innovative life sciences, telecommunication services, utilities, and information technology sectors. In innovative life sciences, it prefers to invest in diagnostics, biopharmaceuticals, medical device research and development, pharmaceuticals, platform technologies, and companies seeking to develop breakthrough products for unmet medical needs with a special focus on new drug discovery- small molecules, biologics and new modalities including med tech, enabling technologies and vaccines. In information technology, the firm focuses on communications, clean technology, digital media & Internet, e-commerce, semiconductor & components, and software & services.
Advent Venture Partners has made 78 investments as of February 2019.It has had 27 exits. The most notable exits include Farfetch, WorldStores, and Dailymotion.
Advent Venture Partners has raised a total of $492.6M across 3 funds. The Advent Life Sciences Fund II LP was announced on Sep 10, 2014, and raised a total of $146.3M.
It focuses on investments in the United Kingdom, Western European, Europe, and the United States. Within Western European markets, it prefers to invest in Andorra, Portugal, and Spain. Within Utilities, it prefers to invest in Alternate energy Resources, Independent power producers, and energy traders.
The firm typically invests between £5 million ($9.46 million) and £15 million ($29 million) in its portfolio companies. Its technology investments focus on startups with sales above €4 million ($5.7 million) and which are often seeking external capital for the first time. For information technology investments, the firm prefers to take small minority positions to full buyouts and a majority stake in a portfolio company. It seeks to take a board seat in its portfolio companies.
Series D - WorldStores
Advent Life Sciences Fund II LP
Series D - Farfetch
Series D - Versartis
Series B - Acutus Medical
Series C - Versartis
Series C - WorldStores
Series C - Farfetch
Series C - Versartis
Series A - NeRRe Therapeutics
Venture Round - F2G
Life sciences fund I
Advent Private Equity Fund IV
Founded in London in 2008 by Portuguese entrepreneur José Neves, Farfetch is an online platform for fashion ecommerce.
A molecular diagnostics for oncology company
A molecular diagnostics company developing technologies for the detection, quantification and amplification of bio-analytes
Conatus Pharmaceuticals is a San Diego-based company.
A heart rhythm technology company that diagnose and treat cardiac arrhythmias
A company developing robotic endoscopic technology for transluminal endoscopic surgery
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
Alan E. Walts
Andrew J Wood
Ian J. Nicholson
A French VC Shows off a New Fund -- and Growing Interest in Europe
Advent gears up for launch of third life sciences fund | Unquote
Advent Venture Partners
Advent Venture Partners Announces Final Close of First Life Sciences Venture Fund | FierceBiotech
Advent Venture Partners Start Life Science Fund with $118M
Fashion Marketplace Farfetch Raises $86M Led By DST At A $1B Valuation
Felix Capital At The Intersection Of Creativity And Tech - Informilo
Financial Conduct Authority
Fizzback bags $5m from Advent Venture Partners - Econsultancy
Fred Destin of Accel Partners on What's Changing (Fast) in Europe
Future Of Cancer Treatment: Immunotherapy Startups Take Lion's Share of Oncology Deals
Investment in Farfetch.com by Advent Venture Partners
Markham Rae Appoints Kah Chye Tan and Sir David Cooksey to Markham Rae Trade Capital Partners Advisory Board
Markham Rae (UK) Ltd.
Petroni Vineyards Grows from Humble Roots to Become the Ultimate Sonoma Wine Destination
The International Unicorn Club: 107 Private Companies Outside The US Valued At $1B+
With Felix Capital, Frederic Court brings Silicon Valley-style investment to Europe
Documentaries, videos and podcasts
Frederic Court Interview - video dailymotion
Opportunities rife for Investors in Growth Companies
RANKED: The 22 biggest European venture capital firms in 2016
What Big Ideas are VC's Betting on in Digital Advertising - video dailymotion
Axonics Modulation Technologies